ArticleMovement disorders clinical practice2026

High Cerebrospinal DOPA Decarboxylase Level Predicts Cognitive Decline in Parkinson's Disease.

Andrea Sturchio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.